Chander Bahl

Title: The Innovative Contributions of Chander Bahl

Introduction

Chander Bahl is a notable inventor based in Flemington, NJ, with a significant portfolio of nine patents. His work primarily focuses on advancements in the field of Hepatitis C virus research, contributing to the development of diagnostic tools that aid in the detection of the virus.

Latest Patents

Among his latest patents, Bahl has developed innovative peptides and recombinant proteins that contain Hepatitis C virus core protein sequences. These inventions involve modifications to the amino acids, which are designed to eliminate the proteins' ability to bind to specific anti-HCV murine monoclonal antibodies. The modifications ensure that the proteins can still be utilized in immunoassays for detecting anti-HCV antibodies in individuals infected with the virus. Additionally, he has patented monoclonal antibodies that specifically bind to the HCV core antigen, along with hybridoma cell lines that secrete these antibodies. His patents also include methods for producing and utilizing these antibodies, including kits that incorporate them.

Career Highlights

Chander Bahl has had a distinguished career, working with prominent companies such as Ortho Diagnostic Systems Inc. and Ortho-Clinical Diagnostics, Inc. His contributions in these organizations have significantly advanced the field of diagnostic testing for Hepatitis C.

Collaborations

Bahl has collaborated with notable colleagues, including Leopoldo G Mendoza and Rhonda Lang, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Chander Bahl's innovative work in the field of Hepatitis C research has led to significant advancements in diagnostic methods. His contributions continue to play a crucial role in improving the detection and understanding of the virus.